Metabolism-associated fatty liver disease (MAFLD) is a multifaceted disease that involves
complex interactions between various organs, including the gut and heart. It is defined by …

Human aging, a natural process characterized by structural and physiological changes,
leads to alterations of homeostatic mechanisms, decline of biological functions, and …

Non-alcoholic steatohepatitis (NASH) is the progressive stage of non-alcoholic fatty liver
disease (NAFLD). The non-absorbable antibiotic rifaximin has been used for treatment of …

Non-alcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver
disease worldwide. It refers to a range of liver conditions affecting people who drink little or …

The intestinal barrier protects our body from external insults through specialized cells
organized in a multilayered structure that evolved in symbiosis with the resident microbiota …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide,
reflecting the current epidemics of obesity, insulin resistance, type 2 diabetes mellitus, and …

Over the past two decades, non-alcoholic fatty liver disease (NAFLD) has become a leading
burden of hepatocellular carcinoma and liver transplantation. Although the exact …

The human gastrointestinal tract, boasting the most diverse microbial community, harbors
approximately 100 trillion microorganisms comprising viruses, bacteria, fungi, and archaea …

The lymphatic fluid is the conduit by which part of the tissue" omics" is transported to the
draining lymph node for immunosurveillance. Following cannulation of the pre-nodal …

Non-alcoholic fatty liver disease (NAFLD) is a multifactorial complicated condition, reflected
by the accumulation of extra fat in the liver. A detailed study of literature throws light on the …